DOCK2
DOCK2 (dedicator of cytokinesis 2, also known as KIAA0209) is a guanine nucleotide exchange factor of the DOCK family that activates RAC1 and RAC2. It drives the cytoskeletal rearrangements that allow lymphocytes to migrate in response to chemokines. Browse Assay Genie's current range of DOCK2 research reagents below, or read on for the biology behind the target.
DOCK2 is a guanine nucleotide exchange factor (GEF). It activates monomeric GTPases by catalysing the release of bound GDP in exchange for free GTP. Its substrates are RAC1 and RAC2, and it does not activate CDC42. Through this activity DOCK2 is involved in the remodelling of the actin cytoskeleton required for lymphocyte migration in response to chemokine signalling. It may also take part in transcriptional activation of IL2 through activation of RAC2.
The DOCK2 gene encodes a protein of the CDM family, which belongs to the wider DOCK family of Rho GEFs. HGNC also places it among the armadillo-like helical domain-containing and SH3 domain-containing genes, and lists it as a microRNA protein-coding host gene. The protein is found in the endomembrane system and in the cytoskeleton. According to NCBI Gene, expression is specific to haematopoietic cells and is highest in peripheral blood leukocytes. This restricted pattern fits its role in immune cell motility. The mouse ortholog is Dock2.
Mutations in DOCK2 cause immunodeficiency 40 (IMD40), a combined immunodeficiency that affects T cell number and function, with variable defects in B cell and NK cell function. The gene was first catalogued as KIAA0209, and earlier HGNC records used the name dedicator of cyto-kinesis 2. Related family members include DOCK1 and DOCK4, which share the DOCK family architecture.
DOCK2 links chemokine signalling to the actin remodelling that lymphocytes need in order to migrate.
As a GEF specific for RAC1 and RAC2 but not CDC42, DOCK2 is a useful model for GTPase selectivity.
Mutations in DOCK2 cause immunodeficiency 40, affecting T cell number and function, with variable B cell and NK cell defects.
DOCK2 is specifically expressed in haematopoietic cells, predominantly in peripheral blood leukocytes, making it a marker of immune cell function.
DOCK2 is a guanine nucleotide exchange factor that promotes release of GDP so that GTP can bind, activating RAC1 and RAC2 but not CDC42. This supports cytoskeletal rearrangements needed for lymphocyte migration in response to chemokines, and it may contribute to IL2 transcriptional activation via RAC2.
The HGNC name is dedicator of cytokinesis 2, and UniProt lists dedicator of cytokinesis protein 2. KIAA0209 is an alias, and an earlier HGNC name was dedicator of cyto-kinesis 2. NCBI Gene describes it as a member of the CDM protein family, part of the DOCK family.
Mutations in DOCK2 result in immunodeficiency 40, a combined immunodeficiency affecting T cell number and function, with variable B cell and NK cell defects. A mouse ortholog, Dock2, exists. Check the datasheet of any product for its validated reactivity.
Other DOCK family Rho GEFs with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q92608; product specifications from Assay Genie datasheets.